Enter Aventis, tech giant

January 1999
Chemical Week;1/6/1999, Vol. 161 Issue 1, p46
Trade Publication
Focuses on the merger agreement between Rhone Poulenc and Aventis. Significance of the merger; Plan of Aventis to establish a technology council to oversee the research & development integration; Comments from Hoechst board member Horst Waesche.


Related Articles

  • EC Forces Aventis To Divest Business.  // Chemical Market Reporter;08/16/99, Vol. 256 Issue 7, p8 

    Reports that Hoechst and Rhone-Poulenc have to license or sell some of their businesses in pharmaceuticals and agrochemicals to gain the European Commission's approval for their merger into Aventis. Plan of the companies for their cobalamines sector; Other plans of the companies.

  • Aventis draws praise from analysts. Mirasol, Feliza // Chemical Market Reporter;12/14/98, Vol. 254 Issue 24, p10 

    Highlights analysts' views on Aventis, the life sciences company created by Hoechst AG and Rhone-Poulenc SA. Research and development budget for Aventis; Aventis' need to strengthen its operations to post the high profits of other giant pharmaceutical manufacturers.

  • Drugs giant seeks global agency. Killgren, Lucy // Marketing Week;2/25/1999, Vol. 22 Issue 4, p12 

    Reports that pharmaceutical giant Aventis, formed by the merger of Rhone-Poulenc and Hoechst, is seeking a global advertising agency to create a worldwide campaign to launch its new name. Five agencies Aventis has talked to; Background information on products.

  • Rhone-Poulenc and Fernz in agrochemical joint venture.  // Chemical Business;Aug97, Vol. 11 Issue 1, p61 

    Reports that Rhone-Poulenc and Fernz Corporation of Australia want to set up a joint venture for the production of oxynil herbicides. Shares of both companies in the proposed joint venture.

  • Hoechst-RP deal at hand. SCOTT, ALEX // Chemical Week;12/2/1998, Vol. 160 Issue 45, p9 

    Reports on a deal between the Hoechst company and the Rhone-Poulenc (RP) company that would combine their life science businesses. Joint statement issued by the companies; Plans for pesticides activities; Expected total sales of the combined animal health business; Speculation on the Hoechst-RP...

  • Millennium scoops up Rhone-Poulenc's TiO2.  // Chemical Week;10/22/1997, Vol. 159 Issue 40, p8 

    Focuses on the acquisition of Rhone-Poulenc company's (RP) titanium dioxide (TiO2) subsidiary, Thann et Mulhouse by Millennium Chemicals Inc. Schedule of completion of the transaction deal; How the purchase affects Millennium's position as TiO2 maker.

  • Rhone-Poulenc in biotech JV.  // Chemical Week;10/22/1997, Vol. 159 Issue 40, p8 

    Provides information on the formation of a joint venture biotechnology company by Rhone-Poulenc Inc. and Biogemma company. Production capacity of the joint venture company; Brief information of Biogemma.

  • R&D Times Two. Stevens, Tim // Industry Week/IW;05/07/2001, Vol. 250 Issue 7, p49 

    Deals with the integration of research and development (R&D) departments of merging companies. Ways by which merging companies can help their R&D staff through the integration; Benefits of the R&D integration to Aventis, the company formed by the merger between Hoechst AG and Rhone-Poulenc SA;...

  • Aventis SA. Gee, Jack // Industry Week/IW;06/07/99, Vol. 248 Issue 11, p30 

    Presents information on the merger of Hoechst AG and Rhone-Poulenc SA. Details on Aventis SA, the life-sciences company which came out of the merger; Discussion on the plans for Aventis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics